Navigation Links
Allscripts Named to FORTUNE 100 Fastest-Growing Companies List

Strong Revenue Growth, Driven by Growing Demand for Healthcare Information Technology, Places Allscripts 23rd among America's Top Corporate Performers

CHICAGO, Sept. 7 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced that it was named one of FORTUNE magazine's 100 Fastest-Growing Companies for 2007. The list, comprised of public companies, appears in the September 17, 2007 issue of FORTUNE and is available online now at Allscripts, which was ranked No. 23 overall, was one of only seven companies in the healthcare sector to make this year's list.

(Logo: )

"We are pleased to be recognized as one of Fortune's 100 Fastest-Growing Companies for 2007," said Glen Tullman, Chief Executive Officer of Allscripts. "We have experienced strong growth across all of our business lines, which is a great tribute to our organization and the people on the front lines who deliver day in and day out for our clients. It is becoming increasingly clear that information technology is the solution of choice for solving the challenges we face in our healthcare system, and that Allscripts is the go-to company for these solutions."

FORTUNE joined with Zacks Investment Research to compile the list of the 100 Fastest-Growing Companies. In order to qualify for this year's listing, a company must be incorporated in the U.S.; have a minimum market capitalization of $250 million; have a stock price of at least $5; have been trading continuously since June 30, 2004; have revenue and net income for the four quarters ended on or before May 31, 2007 of at least $50 million and $10 million, respectively; and have posted a compound annual growth in revenue and earnings per share of at least 25 percent annually over the three years ended on or before May 31, 2007. All companies that met these criteria were ranked by their revenue growth rate; their EPS growth rate; and their three-year annualized total return to investors for the period ended June 30, 2007.

About Allscripts

Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company's business units provide unique solutions that inform, connect and transform healthcare. Allscripts award-winning software applications include Electronic Health Records, practice management, e-prescribing, document imaging, emergency department, and care management solutions, all offered through the Company's Clinical Solutions units. Additionally, Allscripts provides clinical product education and connectivity solutions for physicians and patients through its Physicians Interactive(TM) unit, and medication fulfillment services through its Medication Services unit. To learn more, visit Allscripts on the Web at

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts' actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company's 2006 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at

SOURCE Allscripts
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Our Attitude To Food Costing Us A Fortune
6. A brush with the U.S. Regulators can cost a fortune
7. Waiting list in British healthcare causing them to shell out a fortune!
8. India to benefit from pharma companies move
9. Doctors not to accept gifts from drug companies
10. Pharmaceutical companies are targeting patients
11. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
Post Your Comments:
(Date:11/28/2015)... , ... November 28, 2015 , ... Pixel Film Studios ... media panels to choose from, the possibilities are endless. Users have full control over ... the ProPanel: Pulse masking effects, users are sure to get heads to turn. , ...
(Date:11/27/2015)... ... , ... The rapid speed at which Americans are aging ... is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. ... part of this equation: 80 percent of medical care occurs in the home, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, ... that are presently affecting Americans. Dedicated to providing the world with a wide variety ... consumers focus on, one episode at a time. , In the latest installment ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
Breaking Medicine Technology: